BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38469735)

  • 21. Genomic Landscapes of Acral Melanomas in East Asia.
    Chang JW; Hsieh JJ; Wu CE; Lim AH; Ng CC; Teh BT; Chan JY
    Cancer Genomics Proteomics; 2021; 18(1):83-92. PubMed ID: 33419898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune response-associated gene profiling in Japanese melanoma patients using multi-omics analysis.
    Akiyama Y; Kiyohara Y; Yoshikawa S; Otsuka M; Kondou R; Nonomura C; Miyata H; Iizuka A; Ashizawa T; Ohshima K; Urakami K; Nagashima T; Kusuhara M; Sugino T; Yamaguchi K
    Oncol Rep; 2018 Mar; 39(3):1125-1131. PubMed ID: 29286146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based population.
    Pjanova D; Engele L; Randerson-Moor JA; Harland M; Bishop DT; Newton Bishop JA; Taylor C; Debniak T; Lubinski J; Kleina R; Heisele O
    Melanoma Res; 2007 Jun; 17(3):185-91. PubMed ID: 17505264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low incidence of KIT gene mutations and no PDGFRA gene mutations in primary cutaneous melanoma: an immunohistochemical and molecular genetic study of Japanese cases.
    Terada T
    Int J Clin Oncol; 2010 Oct; 15(5):453-6. PubMed ID: 20425130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metaanalysis of BRAF mutations and clinicopathologic characteristics in primary melanoma.
    Kim SY; Kim SN; Hahn HJ; Lee YW; Choe YB; Ahn KJ
    J Am Acad Dermatol; 2015 Jun; 72(6):1036-46.e2. PubMed ID: 25819940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mapping the single-cell landscape of acral melanoma and analysis of the molecular regulatory network of the tumor microenvironments.
    He Z; Xin Z; Yang Q; Wang C; Li M; Rao W; Du Z; Bai J; Guo Z; Ruan X; Zhang Z; Fang X; Zhao H
    Elife; 2022 Jul; 11():. PubMed ID: 35894206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of recurrence patterns in acral versus nonacral melanoma: should histologic subtype influence treatment guidelines?
    Gumaste PV; Fleming NH; Silva I; Shapiro RL; Berman RS; Zhong J; Osman I; Stein JA
    J Natl Compr Canc Netw; 2014 Dec; 12(12):1706-12. PubMed ID: 25505211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High G2 and S-phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosis.
    Xu T; Ma M; Chi Z; Si L; Sheng X; Cui C; Dai J; Yu S; Yan J; Yu H; Wu X; Tang H; Yu J; Kong Y; Guo J
    Cancer Sci; 2018 Jun; 109(6):1787-1798. PubMed ID: 29660787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole exome sequencing and transcriptome-wide profiling identify potentially subtype-relevant genes of nasopharyngeal carcinoma.
    Liu J; Li X; Yang S; Mou J; Lu H
    Pathol Res Pract; 2020 Dec; 216(12):153244. PubMed ID: 33113455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A unique gene expression signature is significantly differentially expressed in tumor-positive or tumor-negative sentinel lymph nodes in patients with melanoma.
    Tarhini AA; Floros T; Lin HM; Lin Y; Rahman Z; Ashraf M; Vallabhaneni P; Sander C; Rao UNM; Panelli M; LaFramboise WA; Kirkwood JM
    Melanoma Res; 2017 Oct; 27(5):429-438. PubMed ID: 28825947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple primary acral melanomas in two young caucasian patients.
    Lacruz G; Cárdenas I; Carrera C; Díaz A; Puig-Butillè JA; Badenas C; Malvehy J; Puig S
    Dermatology; 2014; 228(4):307-10. PubMed ID: 24942556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity.
    Newell F; Wilmott JS; Johansson PA; Nones K; Addala V; Mukhopadhyay P; Broit N; Amato CM; Van Gulick R; Kazakoff SH; Patch AM; Koufariotis LT; Lakis V; Leonard C; Wood S; Holmes O; Xu Q; Lewis K; Medina T; Gonzalez R; Saw RPM; Spillane AJ; Stretch JR; Rawson RV; Ferguson PM; Dodds TJ; Thompson JF; Long GV; Levesque MP; Robinson WA; Pearson JV; Mann GJ; Scolyer RA; Waddell N; Hayward NK
    Nat Commun; 2020 Oct; 11(1):5259. PubMed ID: 33067454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic Aberrations in the CDK4 Pathway Are Associated with Innate Resistance to PD-1 Blockade in Chinese Patients with Non-Cutaneous Melanoma.
    Yu J; Yan J; Guo Q; Chi Z; Tang B; Zheng B; Yu J; Yin T; Cheng Z; Wu X; Yu H; Dai J; Sheng X; Si L; Cui C; Bai X; Mao L; Lian B; Wang X; Yan X; Li S; Zhou L; Flaherty KT; Guo J; Kong Y
    Clin Cancer Res; 2019 Nov; 25(21):6511-6523. PubMed ID: 31375512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different progression pattern between acral and nonacral melanoma: A retrospective, comparative, clinicoprognostic study of 492 cases of primary cutaneous melanoma according to tumor site.
    Jung JM; Jung CJ; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
    Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):498-508. PubMed ID: 33871216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-200a Regulates CDK4/6 Inhibitor Effect by Targeting CDK6 in Metastatic Melanoma.
    Bustos MA; Ono S; Marzese DM; Oyama T; Iida Y; Cheung G; Nelson N; Hsu SC; Yu Q; Hoon DSB
    J Invest Dermatol; 2017 Sep; 137(9):1955-1964. PubMed ID: 28526299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential Prognostic Predictors and Molecular Targets for Skin Melanoma Screened by Weighted Gene Co-expression Network Analysis.
    Chen S; Liu Z; Li M; Huang Y; Wang M; Zeng W; Wei W; Zhang C; Gong Y; Guo L
    Curr Gene Ther; 2020; 20(1):5-14. PubMed ID: 32416689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TERT promoter mutation is uncommon in acral lentiginous melanoma.
    Liau JY; Tsai JH; Jeng YM; Chu CY; Kuo KT; Liang CW
    J Cutan Pathol; 2014 Jun; 41(6):504-8. PubMed ID: 24588324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas.
    Rawson RV; Johansson PA; Hayward NK; Waddell N; Patch AM; Lo S; Pearson JV; Thompson JF; Mann GJ; Scolyer RA; Wilmott JS
    Lab Invest; 2017 Feb; 97(2):130-145. PubMed ID: 28067894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BRAF, KIT, and NRAS Mutations of Acral Melanoma in White Patients.
    Dika E; Veronesi G; Altimari A; Riefolo M; Ravaioli GM; Piraccini BM; Lambertini M; Campione E; Gruppioni E; Fiorentino M; Melotti B; Ferracin M; Patrizi A
    Am J Clin Pathol; 2020 Apr; 153(5):664-671. PubMed ID: 32017841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel mutations identified by whole-exome sequencing in acral melanoma.
    Lim Y; Yoon D; Lee DY
    J Am Acad Dermatol; 2020 Dec; 83(6):1792-1794. PubMed ID: 32278801
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.